These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2894001)

  • 1. A single point mutation responsible for c-mos polymorphism in cancer patients.
    Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic polymorphism and susceptibility to cancer].
    Larsen CJ
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
    Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
    Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer.
    Lemoine NR; Staddon S; Dickson C; Barnes DM; Gullick WJ
    Oncogene; 1990 Feb; 5(2):237-9. PubMed ID: 2181382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of the proto-oncogene ETS-1 in hematological malignancies.
    Kerckaert JP; Duterque-Coquillaud M; Collyn-d'Hooghe M; Morel P; Majérus MA; Laï JL; Fenaux P; Bauters F; Debuire B; Loucheux-Lefebvre MH
    Leukemia; 1990 Jan; 4(1):16-9. PubMed ID: 1967322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
    Ishikawa J; Maeda S; Kamidono S; Sugiyama T
    Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA restriction fragment length polymorphisms at either end of the c-raf-1 locus at 3p25.
    Graziano SL; Mark GE; Murray C; Mann DL; Ehrlich GD; Poiesz BJ; Weston A
    Oncogene Res; 1988; 3(1):99-103. PubMed ID: 2905034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the c-Ha-ras-1 locus polymorphism in an Italian population with high incidence of gastric cancer.
    Ranzani GN; Salerno-Mele P; Maltoni M; Talarico D; Della Valle G; Amadori D
    Mol Biol Med; 1988 Dec; 5(3):145-53. PubMed ID: 2907601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
    Weismanová E; Kalúz S; Skorvaga M
    Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
    Lidereau R; Mathieu-Mahul D; Theillet C; Renaud M; Mauchauffé M; Gest J; Larsen CJ
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7068-70. PubMed ID: 2996003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.
    Weise B; Ghebremedhin E; Zschunke F; Radzun HJ
    Gen Diagn Pathol; 1996 Jun; 142(1):45-52. PubMed ID: 8793486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphism of restriction fragments of the Ha-ras-1 protooncogene in patients with carcinoma and ulcers of the stomach].
    Novikov LB; Fedorov SN; Iatsuk OS; Tlevlesov NIa; Levanova GI; Kalinovskiĭ VP; Seĭts IF
    Eksp Onkol; 1989; 11(5):66-70. PubMed ID: 2571493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic variation of the c-raf-1 proto-oncogene in human lymphoma and leukemia.
    Trench GC; Southall M; Smith P; Kidson C
    Oncogene; 1989 Apr; 4(4):507-10. PubMed ID: 2566145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oncogenes and tumor suppressor genes of human breast cancer].
    Takita K; Sato T; Nakamura Y
    Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):305-13. PubMed ID: 8098157
    [No Abstract]   [Full Text] [Related]  

  • 18. A frequent restriction fragment length polymorphism in the human metallothionein-II processed gene region is evolutionarily conserved.
    Varshney U; Hoar DI; Starozik D; Gedamu L
    Mol Biol Med; 1984 Jun; 2(3):193-206. PubMed ID: 6100387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated N-ras in a human rectal carcinoma cell line associated with clonal homozygosity in myb locus-restriction fragment polymorphism.
    Yuasa Y; Reddy EP; Rhim JS; Tronick SR; Aaronson SA
    Jpn J Cancer Res; 1986 Jul; 77(7):639-47. PubMed ID: 3017909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.
    Blasiak J; Przybyłowska K; Czechowska A; Zadrozny M; Pertyński T; Rykała J; Kołacińska A; Morawiec Z; Drzewoski J
    Acta Biochim Pol; 2003; 50(1):249-53. PubMed ID: 12673366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.